ASC amino acid transporter 2, defined by enzyme‐mediated activation of radical sources, enhances malignancy of GD2‐positive small‐cell lung cancer

Publisher： John Wiley & Sons Inc

E-ISSN： 1349-7006|109|1|141-153

ISSN： 1347-9032

Source： Cancer Science, Vol.109, Iss.1, 2018-01, pp. : 141-153

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

New metastatic model of human small‐cell lung cancer by orthotopic transplantation in mice

By  

Cancer Science, Vol. 106, Iss. 4, 2015-04 ,pp. : 367-374

John Wiley & Sons Inc

Access to resources Recommend Favorite

Persistent activation of STAT3 by PIM2‐driven positive feedback loop for epithelial‐mesenchymal transition in breast cancer

By  

Cancer Science, Vol. 106, Iss. 6, 2015-06 ,pp. : 718-725

John Wiley & Sons Inc

Access to resources Recommend Favorite

Significant role of Psf3 expression in non‐small‐cell lung cancer

By  

Cancer Science, Vol. 106, Iss. 11, 2015-11 ,pp. : 1625-1634

John Wiley & Sons Inc

Access to resources Recommend Favorite

miR‐335 inhibited cell proliferation of lung cancer cells by target Tra2β

By  

Cancer Science, Vol. 109, Iss. 2, 2018-02 ,pp. : 289-296

John Wiley & Sons Inc

Access to resources Recommend Favorite

Acquisition of cancer stem cell‐like properties in non‐small cell lung cancer with acquired resistance to afatinib

By  

Cancer Science, Vol. 106, Iss. 10, 2015-10 ,pp. : 1377-1384

John Wiley & Sons Inc

Access to resources Recommend Favorite